ES2171278T3 - Presentacion en forma de lamina de dosis individual, que se descompone rapidamente en contacto con un liquido, y contiene una sustancia activa, en particular una sustancia aromatica. - Google Patents

Presentacion en forma de lamina de dosis individual, que se descompone rapidamente en contacto con un liquido, y contiene una sustancia activa, en particular una sustancia aromatica.

Info

Publication number
ES2171278T3
ES2171278T3 ES97952796T ES97952796T ES2171278T3 ES 2171278 T3 ES2171278 T3 ES 2171278T3 ES 97952796 T ES97952796 T ES 97952796T ES 97952796 T ES97952796 T ES 97952796T ES 2171278 T3 ES2171278 T3 ES 2171278T3
Authority
ES
Spain
Prior art keywords
liquid
active substance
contact
phase
presentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97952796T
Other languages
English (en)
Inventor
Michael Horstmann
Wolfgang Laux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2171278T3 publication Critical patent/ES2171278T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Laminated Bodies (AREA)

Abstract

LA INVENCION SE REFIERE A UNA PRESENTACION EN FORMA DE LAMINA, DOSIFICADA INDIVIDUALMENTE, QUE SE DESCOMPONE RAPIDAMENTE EN CONTACTO CON UN LIQUIDO Y QUE CONTIENE UNA SUSTANCIA ACTIVA, EN PARTICULAR UNA SUSTANCIA AROMATICA, SIENDO DICHA SUSTANCIA AROMATICA UNA FASE INTERIOR SOLUBLE EN GRASA, DISTRIBUIDA EN FORMA DE PEQUEÑAS GOTAS DE LIQUIDO EN UNA FASE EXTERIOR SOLIDA PERO SOLUBLE EN AGUA. LA PRESENTACION SE CARACTERIZA PORQUE LA FASE EXTERIOR COMPRENDE AL MENOS UN 40% (G/G) DE ALCOHOL POLIVINILICO Y DE UN 0 A UN 30% (G/G) DE AGENTE SUPERFICIACTIVO, Y PORQUE LA PROPORCION DE LA FASE INTERIOR RESPECTO A LA FASE EXTERIOR SE ENCUENTRA ENTRE EL 0,1 Y EL 30% (G/G), EN CADA CASO EN RELACION CON LAS PARTES ANHIDRAS.
ES97952796T 1996-12-16 1997-11-21 Presentacion en forma de lamina de dosis individual, que se descompone rapidamente en contacto con un liquido, y contiene una sustancia activa, en particular una sustancia aromatica. Expired - Lifetime ES2171278T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19652257A DE19652257A1 (de) 1996-12-16 1996-12-16 Einzeln dosierte, bei Kontakt mit Flüssigkeit schnell zerfallende, wirkstoff- und insbesondere aromastoffhaltige, folienförmige Darreichnungsform

Publications (1)

Publication Number Publication Date
ES2171278T3 true ES2171278T3 (es) 2002-09-01

Family

ID=7814851

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97952796T Expired - Lifetime ES2171278T3 (es) 1996-12-16 1997-11-21 Presentacion en forma de lamina de dosis individual, que se descompone rapidamente en contacto con un liquido, y contiene una sustancia activa, en particular una sustancia aromatica.

Country Status (13)

Country Link
US (2) US6682756B1 (es)
EP (1) EP0949909B1 (es)
JP (2) JP4577913B2 (es)
KR (1) KR100493140B1 (es)
AT (1) ATE211648T1 (es)
AU (1) AU727185B2 (es)
CA (1) CA2274959C (es)
DE (2) DE19652257A1 (es)
DK (1) DK0949909T3 (es)
ES (1) ES2171278T3 (es)
NO (1) NO320503B1 (es)
PT (1) PT949909E (es)
WO (1) WO1998026764A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2338896B (en) 1998-07-02 2003-05-21 Reckitt & Colmann Prod Ltd Chewable Capsules
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6800329B2 (en) * 1999-02-12 2004-10-05 Lts Lohmann Therapie-Systeme Ag Method for producing film-type dosage
DE19905801B4 (de) * 1999-02-12 2008-03-13 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung folienförmiger Darreichungsformen
EP1196137B1 (en) 1999-07-02 2004-12-22 The Procter & Gamble Company Systems comprising organosiloxane resins for delivering oral care substances and for prolonging such delivery
DE10032456A1 (de) * 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen
DE10063945A1 (de) * 2000-12-20 2002-07-04 Henkel Kgaa Remineralisierende Dental-Klebefolie
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
GB2392446A (en) * 2002-09-02 2004-03-03 Reckitt Benckiser Nv Resin comprising water-soluble polymer and water-soluble filler
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
US20050019277A1 (en) * 2002-09-11 2005-01-27 The Procter & Gamble Company Tooth whitening products
US20040136923A1 (en) * 2002-11-14 2004-07-15 Davidson R Steven Edible film for relief of cough or symptoms associated with pharyngitis
US6669929B1 (en) * 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
DE10338544B4 (de) * 2003-08-19 2017-08-31 Janssen Pharmaceutica N.V. Buccale Formulierungen des Galanthamins und deren Anwendungen
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
DE102004017030A1 (de) * 2004-04-02 2005-10-20 Schering Ag Flachkapseln
ES2346470T3 (es) * 2005-08-18 2010-10-15 Colgate-Palmolive Company Composiciones de limpieza que contienen pelicula.
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
US20070148213A1 (en) * 2005-12-22 2007-06-28 Sayed Ibrahim Film containing compositions
US7786027B2 (en) * 2006-05-05 2010-08-31 The Procter & Gamble Company Functionalized substrates comprising perfume microcapsules
ATE468967T1 (de) * 2006-05-05 2010-06-15 Procter & Gamble Folien mit mikrokapseln
US20080014393A1 (en) * 2006-05-05 2008-01-17 The Procter & Gamble Company Functionalized substrates comprising perfume microcapsules
DE102006061287A1 (de) * 2006-12-22 2008-06-26 Lts Lohmann Therapie-Systeme Ag Eßbare folienförmige Zubereitung mit Cola-Geschmack
US9265779B2 (en) 2008-05-13 2016-02-23 Lts Lohmann Therapie-Systeme Ag Method of using a film-shaped preparation comprising oily substances for oral administration
DE102008023345B4 (de) 2008-05-13 2014-12-04 Lts Lohmann Therapie-Systeme Ag Filmförmige Zubereitung mit öligen Substanzen zur oralen Verabreichung
DE102010048408A1 (de) 2010-10-15 2012-04-19 Lts Lohmann Therapie-Systeme Ag Laminat mit verbessertem Wasserretentionsverhalten
DE102017112527B4 (de) 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
WO2020136620A1 (en) 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
WO2020136606A1 (en) 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
WO2025045353A1 (en) * 2023-08-29 2025-03-06 Symrise Ag A fragrance pod

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA492040A (en) 1953-04-14 General Motors Corporation Shock absorber
US3265630A (en) * 1958-12-22 1966-08-09 Ncr Co Encapsulating lipophilic material by coacervation
GB1142325A (en) 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
US3434843A (en) * 1967-03-08 1969-03-25 Pillsbury Co Stable food pieces
DE2449865B2 (de) 1974-10-17 1981-06-19 Schering Ag Berlin Und Bergkamen, 1000 Berlin Folienförmiges Arzneimittel
ZA767136B (en) * 1975-12-15 1977-10-26 Hoffmann La Roche Novel dosage form
AU514195B2 (en) * 1975-12-15 1981-01-29 F. Hoffmann-La Roche & Co. Dosage form
US4119604A (en) * 1976-08-18 1978-10-10 E. I. Du Pont De Nemours And Company Polyvinyl alcohol compositions for use in the preparation of water-soluble films
JPS5455740A (en) * 1977-10-05 1979-05-04 Koyo Sangyo Co Room aromatizing agent
US4481326A (en) * 1980-12-15 1984-11-06 Colgate Palmolive Company Water soluble films of polyvinyl alcohol polyvinyl pyrrolidone
US4597959A (en) * 1982-04-30 1986-07-01 Arthur Barr Sustained release breath freshener, mouth and palate coolant wafer composition and method of use
JPS58192811A (ja) 1982-05-04 1983-11-10 Yakult Honsha Co Ltd 皮膚用保湿剤の製造法
JPS59186912A (ja) * 1983-04-07 1984-10-23 Takehiro Takaguchi 香粧香料含有溶解性フイルム
US4528226A (en) * 1983-10-11 1985-07-09 Minnesota Mining And Manufacturing Co. Stretchable microfragrance delivery article
USRE33299E (en) * 1984-12-11 1990-08-14 Minnesota Mining And Manufacturing Company Fragrance-releasing pull apart sheet
EP0219762B1 (de) 1985-10-09 1990-12-27 Desitin Arzneimittel GmbH Verfahren zur Herstellung einer Darreichungs- und Dosierungsform für Arzneimittel-Wirkstoffe, Reagentien oder andere Wirkstoffe
DE3630603A1 (de) 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
EP0303445A1 (en) * 1987-08-13 1989-02-15 Walton S.A. Clebopride transdermal patch
US4900552A (en) * 1988-03-30 1990-02-13 Watson Laboratories, Inc. Mucoadhesive buccal dosage forms
JPH01279838A (ja) * 1988-04-30 1989-11-10 Kiyuukiyuu Yakuhin Kogyo Kk 塩化リゾチーム含有歯肉炎・歯槽膿漏用貼付剤
US5047244A (en) 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
JPH0259513A (ja) * 1988-08-24 1990-02-28 Kiyuukiyuu Yakuhin Kogyo Kk 口腔粘膜貼付型口臭防止剤
US4946684A (en) 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
WO1991005540A1 (de) 1989-10-14 1991-05-02 Desitin Arzneimittel Gmbh Mund- und zahnpflegemittel
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
US5290547A (en) * 1990-10-31 1994-03-01 Ronald T. Dodge Co. Macroemulsion having an odor-counteracting discontinuous phase
FI942765L (fi) 1991-12-11 1994-06-10 Procter & Gamble Setyylipyridiniumkloridi ja domifeenibromidi orgaanisessa liottimessa
JP3414423B2 (ja) * 1992-11-27 2003-06-09 積水化学工業株式会社 眠気防止用外用剤及び貼付剤
US5580491A (en) 1993-07-13 1996-12-03 Cornell Research Foundation, Inc. Foamable whey protein composition
CN1134163A (zh) * 1993-08-19 1996-10-23 辛勒斯治疗系统公司 水溶性压敏粘膜粘合剂和配备该粘合剂用于放置在有粘膜衬里的体腔内的器具
US6126953A (en) 1996-08-19 2000-10-03 The Procter & Gamble Company Fragrance delivery systems for personal care articles
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US6183757B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing

Also Published As

Publication number Publication date
JP2010270133A (ja) 2010-12-02
KR100493140B1 (ko) 2005-06-02
US8883191B2 (en) 2014-11-11
EP0949909A1 (de) 1999-10-20
JP2001505884A (ja) 2001-05-08
DE59706140D1 (de) 2002-02-28
EP0949909B1 (de) 2002-01-09
KR20000057564A (ko) 2000-09-25
AU5654898A (en) 1998-07-15
US20040137027A1 (en) 2004-07-15
NO992908L (no) 1999-06-14
PT949909E (pt) 2002-06-28
ATE211648T1 (de) 2002-01-15
DE19652257A1 (de) 1998-06-18
CA2274959C (en) 2006-08-08
DK0949909T3 (da) 2002-04-22
JP4577913B2 (ja) 2010-11-10
US6682756B1 (en) 2004-01-27
WO1998026764A1 (de) 1998-06-25
NO320503B1 (no) 2005-12-12
NO992908D0 (no) 1999-06-14
CA2274959A1 (en) 1998-06-25
AU727185B2 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
PT949909E (pt) Forma de apresentacao com a forma de folha doseada individualmente que se desagrega rapidamente por contacto com liquido contendo uma substancia activa e especialmente uma substancia aromatica
DK13688D0 (da) Terapeutisk system for tungtoploeselige aktive stoffer
UA29469C2 (uk) Ліпосомальна фармацевтична композиція для внутрішньовенного введення
ES2130420T3 (es) Preparado transdermico de sustancia activa.
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
SE9600071D0 (sv) New oral formulation of two active ingredients I
DK0851753T3 (da) Aerosolpræparater
ES2010226A6 (es) Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos
MY112093A (en) Cosmetic delivery system for salicylic acid and process for preparation of the same.
EP1452172A3 (en) Multiple unit pharmaceutical preparation
CA2281473A1 (en) Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
DE60112102D1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
EP1285667A3 (en) Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
CA2117769A1 (en) Liposome composition
BG103325A (en) Analgetic preparation for external application
AR020391A1 (es) Formulaciones microencapsuladas, un procedimiento para su obtencion y empleo de dichas formulaciones.
DE3852409D1 (de) Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen.
FI962056A0 (fi) Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
ES2060293T3 (es) Nueva sustancia antiulcerosa.
KR920002165A (ko) 리포좀 생성물
NZ512194A (en) A pharmaceutical composition comprising cyclosporin in a lipid carrier
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ES2007040A6 (es) Un forma de dosificacion para descargar un agente benificioso a un entorno fluido de uso
AR000922A1 (es) Productos para combatir hongos nocivos que contienen derivados de p-hidroxifenilanilina como agente activo, aplicacion de dichos derivados paracombatir hongos nocivos y procedimiento para combatir hongos nocivos con aplicacion de dichos productos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 949909

Country of ref document: ES